Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “derivative”

1,342 pharma patents match "derivative" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,342
Index total 30,257
Page 8 / 56

Quick answer

This filtered view shows 1,342 pharmaceutical patents matching "derivative" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,342 results for “derivative” · 30,257 patents in full index Clear search

  1. US 11191855

    1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof

    UNIVERSITÄTSKLINIKUM REGENSBURG · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  2. US 11186576

    Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK inhibitors

    Aurigene Discovery Technologies Limited · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted
  3. US 11186602

    Glucopyranosyl derivative and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted
  4. US 11180484

    Pyrazole derivatives as plasma kallikrein inhibitors

    KalVista Pharmaceuticals Limited · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  5. US 11180518

    Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma

    Ludwig-Maximilians-Universitat Munchen · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  6. US 11179376

    Salts of pyrazolo[1,5-a]pyridine derivative and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  7. US 11180466

    2-benzoylaminobenzamide derivatives as Bcl-3 inhibitors

    University College Cardiff Consultants Limited · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted
  8. US 11174232

    Substituted heterocyclyl derivatives as CDK inhibitors

    Aurigene Discovery Technologies Limited · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  9. US 11166960

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  10. US 11155525

    Azole derivatives as apelin receptor agonist

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  11. US 11147801

    Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Aurigene Discovery Technologies Limited · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted
  12. US 11141496

    Use of berberine or derivative thereof in preparing myocardial perfusion imaging agent

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  13. US 11130759

    2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

    IDEAYA Biosciences, Inc. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted
  14. US 11130772

    CYP-eicosanoid derivatives

    The Board of Regents of the University of Texas System · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted
  15. US 11130753

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted
  16. US 11117899

    [1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor

    Medshine Discovery Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  17. US 11111238

    Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer

    Lead Discovery Center GmbH · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  18. US 11104706

    Ang (1-7) derivative oligopeptides and methods for using and producing the same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  19. US 11098054

    Englerin derivatives for treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Sciences · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  20. US 11090290

    Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy

    Monopar Therapeutics Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  21. US 11084798

    2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

    IDEAYA Biosciences, Inc. · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted
  22. US 11084842

    Glucopyranosyl derivative and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted
  23. US 11072581

    N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors

    Oxford Drug Design Limited · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  24. US 11072600

    Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer

    The Regents of the University of California · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted